多功能微尺度超声对比剂用于恶性肿瘤的精准治疗学。
Multifunctionalized Microscale Ultrasound Contrast Agents for Precise Theranostics of Malignant Tumors.
机构信息
Guangdong Provincial Key Laboratory of Optical Information Materials and Technology & Institute of Electronic Paper Displays, South China Academy of Advanced Optoelectronics, South China Normal University, Guangzhou 510006, China.
National Center for International Research on Green Optoelectronics, South China Normal University, Guangzhou 510006, China.
出版信息
Contrast Media Mol Imaging. 2019 Jul 7;2019:3145647. doi: 10.1155/2019/3145647. eCollection 2019.
In ultrasonography, ultrasound contrast agents (UCAs) that possess high acoustic impedance mismatch with the bulk medium are frequently employed to highlight the borders between tissues by enhanced ultrasound scattering in a clinic. Typically, the most common UCA, microbubble, is generally close in size to a red blood cell (<∼10 μm). These microscale UCAs cannot be directly entrapped into the target cells but generate several orders of magnitude stronger echo signals than the nanoscale ones. And their large containment and high ultrasound responsiveness also greatly facilitate to perform combined treatments, e.g., drug delivery and other imaging techniques. So multifunctionalized microscale UCAs appear on this scene and keep growing toward a promising direction for precise theranostics. In this review, we systematically summarize the new advances in the principles and preparations of multifunctionalized microscale UCAs and their medical applications for malignant tumors.
在超声中,常使用具有与主体介质高声阻抗失配的超声造影剂(UCAs)来增强超声散射,以突出组织之间的边界,从而在临床上进行应用。通常,最常见的 UCA,即微泡,其大小与红细胞相近(<∼10μm)。这些微尺度的 UCAs 不能直接被靶细胞捕获,但会产生比纳米级 UCAs 强几个数量级的回波信号。此外,它们较大的容纳空间和较高的超声响应性也极大地促进了联合治疗的进行,例如药物输送和其他成像技术。因此,多功能微尺度 UCAs 应运而生,并朝着精确治疗的有前途的方向发展。在这篇综述中,我们系统地总结了多功能微尺度 UCAs 的原理和制备方法及其在恶性肿瘤方面的医学应用的新进展。
相似文献
Contrast Media Mol Imaging. 2019-7-7
Curr Pharm Des. 2017
Nanomedicine (Lond). 2017-1
Cancer Lett. 2019-11-29
IEEE Trans Ultrason Ferroelectr Freq Control. 2013-1
Abdom Radiol (NY). 2018-4
引用本文的文献
本文引用的文献
ACS Appl Mater Interfaces. 2018-4-19
Curr Pharm Des. 2017
Colloids Surf B Biointerfaces. 2017-3-1